Interleukin 3 activates human blood basophils via high-affinity binding sites.
about
Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulationThe PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophilsMolecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen familyAcute side effects of homologous interleukin-3 in rhesus monkeys.Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a.The immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction.Mast cell activation syndromes: definition and classification.1995 Mack-Forster Award Lecture. Review. Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes.Human cord blood derived immature basophils show dual characteristics, expressing both basophil and eosinophil associated proteins.Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbuminCharacterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapyRecognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense.Vaccination with genetically engineered allergens prevents progression of allergic disease.Basophil-derived IL-6 regulates TH17 cell differentiation and CD4 T cell immunity.BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils.Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression.Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapyThe role of the basophil in allergic inflammation.Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.Clinical results with recombinant human interleukin-3.Structure-activity relationship study of human interleukin-3: role of the C-terminal region for biological activity.Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping.Molecular and functional characterization of the urokinase receptor on human mast cells.Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations.The differentiation and maturation of inflammatory cells involved in the allergic response: mast cells and basophils.Basophils inhibit proliferation of CD4⁺ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease.Signal transduction of human interleukin 3 and granulocyte-macrophage colony-stimulating factor through serine and tyrosine phosphorylation.Expression and modulation of IL-3 and GM-CSF receptors in human growth factor dependent leukaemic cells.Profilins constitute a novel family of functional plant pan-allergens.Basophils are not the key antigen-presenting cells in allergic patientsQuantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy.Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.The surface membrane antigen phenotype of human blood basophils.Dexamethasone inhibits basophil migration.Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development.
P2860
Q28252822-60C5EF23-086E-478F-9F62-00B5662EC32AQ28480417-FA7219DA-D39A-4825-89EC-D9CB1405FD71Q30904654-A9093177-921B-4680-8E05-CAD5CA62CF94Q33493243-239F5875-3E96-42CD-9C57-CFF17C3538ABQ33774345-2C2A95EC-CA93-481D-A169-B771941E2232Q33852820-B536755C-E668-4835-94F2-7A67F0DAF677Q34035582-0C286152-55CD-4089-8445-B02CDCF75AECQ34371015-7DC40B0E-0675-4EA7-B9AE-C032A269CA51Q34464942-7744F5E6-22C3-4E5A-B919-160D47B5F757Q35360074-85C6CADE-B1E9-4F41-AAF5-F4AFA1CDA6B1Q36069475-0B401989-5D19-4CB2-8445-9F652F5955DAQ36946043-FE026BFA-2E54-4A45-AEA1-5A02AB8FB6F8Q37569798-6001184F-1A57-4B8B-9824-1076541AB063Q37612401-8E0FCBF1-3F6C-4E19-A8D4-05A5FEEE3445Q38711198-C3283A38-D405-4C16-BACC-9B7BF3B49C76Q39089887-9FA3C7E0-CFF9-4FD3-8429-A06A2AACF490Q39276326-160E686F-E31D-4CBC-B2C6-74FF876012B3Q39294830-71338303-F6EA-40F5-9FC1-614E22E08407Q39782156-BECF3520-4BF7-46B0-96E2-90D7EB98B066Q40421720-2909A38A-23A2-4E75-BD89-A6BDDE78A460Q40443526-F6367505-756A-49F5-AB89-8D650441FB22Q40891332-70A901E1-A0F9-4EFC-949A-3A6484B080F6Q41081708-AEB39083-3509-4051-BFFA-2E17C66CA5AAQ41119792-ED71E6F7-65EC-4220-88A5-A7A0E16A7706Q41120291-8021D4E1-D063-4D42-9A1E-CB01EFC5F7B4Q41321280-8AC41750-31AF-4730-942F-85CF5AB98676Q41376803-B551560E-958A-4AE5-BEC7-D4901635CB16Q41643992-CACF228F-1178-46E7-A5B6-C0552E051F05Q41718316-5E6438A9-8395-476C-BCE0-5F3D21E5E2F7Q41719990-7C3366D3-A3CE-4904-8142-5C1CC330148CQ41911475-C51C8ADD-FDED-4493-8C29-061D5C929717Q42591766-D31118F0-D291-48BC-828B-0B13CC8EFCCBQ43818029-A4CD092A-5142-4532-BF7A-BFB04AE0A014Q43848295-65166215-98B8-441A-A096-FD1C819B8965Q44219941-EC0A9DBC-C6EA-4D6F-BA63-D710A9D4ACA9Q46620513-B836738B-2FB2-4D9F-B3F5-62D2652B2F6AQ46715031-8124CD19-3E78-4B38-B8EF-7FE27331FD5DQ50767431-D3DA1BFC-716F-4E45-8F02-A0F7ABEAC6D5Q50773005-49B224AD-2D6C-48E8-B1CA-140C5BD125B8Q53159771-05507C8D-1BC2-4725-B54D-0C881C51D5F7
P2860
Interleukin 3 activates human blood basophils via high-affinity binding sites.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@ast
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@en
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@nl
type
label
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@ast
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@en
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@nl
prefLabel
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@ast
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@en
Interleukin 3 activates human blood basophils via high-affinity binding sites.
@nl
P2093
P2860
P356
P1476
Interleukin 3 activates human blood basophils via high-affinity binding sites
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.14.5542
P407
P50
P577
1989-07-01T00:00:00Z